Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/1998
09/02/1998CN1192219A Reversible cysteine protease inhibitors
09/02/1998CN1192201A N-(aroyl) glycine hydroxamic acid derivatives and related compounds
09/02/1998CN1192157A Method to prevent transplant rejection
09/02/1998CN1192156A Treatment of T cell mediated autoimmune disorders
09/02/1998CN1192153A aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies
09/02/1998CN1192146A 4,4-(disubstituted) cyclohexan-1-ols)-monomers and related compounds
09/02/1998CN1192144A 1H-4(5)-substituted imidazole derivatives
09/02/1998CN1191898A Self-enhancing, pharmacologically controllable expression systems
09/02/1998CN1191738A Huanyang oral liquid
09/01/1998US5801227 Antibodies to CD40
09/01/1998US5801190 Fused pyrrolo 2,3-C! carbazole-6-ones
09/01/1998US5801180 Antiischemic agents and cardiovascular disorders
09/01/1998US5800988 Cdna libraries with nucleotide sequences coded for immunoglobulins with polypeptide chains
09/01/1998US5800808 Copolymer-1 improvements in compositions of copolymers
09/01/1998CA2086874E Methods for administration of taxol
08/1998
08/28/1998CA2230490A1 Novel licc
08/28/1998CA2230478A1 Novel licd2
08/28/1998CA2230473A1 Novel licd1
08/28/1998CA2230467A1 Novel licb
08/27/1998WO1998037224A1 Transgenically produced non-secreted proteins
08/27/1998WO1998037200A2 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
08/27/1998WO1998037099A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics
08/27/1998WO1998037094A2 Secreted proteins and polynucleotides encoding them
08/27/1998WO1998037079A1 N-heterocyclic derivatives as nos inhibitors
08/27/1998WO1998037072A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
08/27/1998WO1998037061A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
08/27/1998WO1998036772A1 Chelating immunostimulating complexes
08/27/1998WO1998036747A1 Pharmaceutical composition
08/27/1998WO1998024782A3 Substituted pyrimidine compounds and their use
08/27/1998WO1998013031A3 Medicinal aerosol formulations comprising budesonide
08/27/1998DE19708454A1 Die Proliferation von Zellen inhibierendes Peptid und dessen Verwendung The proliferation of cells inhibiting peptide and use thereof
08/27/1998CA2742641A1 Compounds for immunotherapy of prostate cancer and methods for their use
08/27/1998CA2281949A1 Transgenically produced non-secreted proteins
08/27/1998CA2281893A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics
08/27/1998CA2281794A1 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
08/27/1998CA2281059A1 Secreted proteins and polynucleotides encoding them
08/26/1998EP0860502A1 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor
08/26/1998EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes
08/26/1998EP0859957A2 Patient-specific immunoadsorbents for extracorporal apheresis and methods of producing said immuno-adsorbers
08/26/1998EP0859834A2 A paf-acetylhydrolase and use in therapy
08/26/1998EP0859787A1 G-protein coupled receptor hnfds78
08/26/1998EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
08/26/1998EP0859771A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
08/26/1998EP0859766A1 Chiral methyl phenyl oxazolidinones
08/26/1998EP0859628A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
08/26/1998EP0859626A1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation
08/26/1998EP0859622A1 Extracts of shark cartilage
08/26/1998EP0859613A2 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system
08/26/1998EP0859601A2 Prolonged release of gm-csf
08/26/1998EP0739336B1 Gem-disubstituted azacyclic tachykinin antagonists
08/26/1998EP0558603B1 Retroviral protease inhibitors
08/26/1998CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists
08/26/1998CN1191483A Use of ipriflavone to reduce number of CD8 + cells
08/26/1998CN1039586C Method for preparing organic salts of N, N'-diacetyl cystine
08/25/1998US5798448 AL-1 neurotrophic factor antibodies
08/25/1998US5798351 Useful for inhibiting bone loss, lowering seum cholesterol levels and treating hormone dependent mammalian breast and uterine cancer
08/25/1998US5798231 Nucleotide sequences for α chain variable regions in human lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
08/25/1998US5798228 Recombinant production of dog and horse type I interferons
08/25/1998US5798100 Multi-stage cascade boosting vaccine
08/25/1998US5798099 Genetic engineering; culture product
08/25/1998CA1340012C Peptide determinant associated with immunity
08/24/1998CA2220855A1 Cdna clone hdpb130 that encodes a novel human 7-transmembrane receptor
08/21/1998CA2224085A1 Aroe
08/20/1998WO1998036070A1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-λB ACTIVATION
08/20/1998WO1998036069A1 Novel human mago nashi protein
08/20/1998WO1998036067A2 Secreted proteins and polynucleotides encoding them
08/20/1998WO1998035983A1 The proliferation of cell-inhibiting peptide and its use
08/20/1998WO1998035966A1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
08/20/1998WO1998035562A1 Polynucleotide vaccine formulations
08/20/1998CA2281033A1 The proliferation of cell-inhibiting peptide and its use
08/20/1998CA2280968A1 Secreted proteins and polynucleotides encoding them
08/20/1998CA2280896A1 Novel human mago nashi protein
08/20/1998CA2280839A1 Polynucleotide vaccine formulations
08/19/1998EP0859054A1 Drug binding protein
08/19/1998EP0859053A1 Novel G-protein coupled receptor (HTADX50)
08/19/1998EP0859000A1 Isoxazole amide and crotonamid derivatives and drug and diagnostic uses thereof
08/19/1998EP0858504A1 Diagnostics and treatments of periodontal disease
08/19/1998EP0858456A1 Triterpene derivatives with immunosuppressant activity
08/19/1998EP0858345A1 Use of muteins of wild-type cytokines as immunogens
08/19/1998EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases
08/19/1998EP0858332A1 Triterpene derivatives with immunosuppressant activity
08/19/1998EP0858327A2 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases
08/19/1998EP0660936B1 Up-converting reporters for biological and other assays using laser excitation techniques
08/19/1998CN1190991A Human chemokine beta-11 and human chemokine alpha-1
08/19/1998CN1190898A Vaccine composition containing polyribosylribitol phosphate and method for making same
08/18/1998US5795966 Antagonists of interleukin-15
08/18/1998US5795908 Fkbp immunophilins for enzyme inhibitors
08/18/1998US5795905 CRF receptor antagonists and methods relating thereto
08/18/1998US5795900 Symmetrical bis-heteroaryl-methoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
08/18/1998US5795580 Group B streptococcus type V polysaccharide-protein conjugate vaccines
08/18/1998US5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it
08/18/1998CA2224123A1 Nucleic acid construct for the cell cycle regulated expression of structural genes
08/18/1998CA2215920A1 Drug binding protein
08/13/1998WO1998034957A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE α-GALACTOSYL EPITOPE
08/13/1998WO1998034929A1 Il-8 receptor antagonists
08/13/1998WO1998034909A1 Bi-aromatic compounds, compositions containing them and uses
08/13/1998WO1998034642A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998WO1998034641A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
08/13/1998WO1998034640A2 Synthetic hiv gag genes
08/13/1998WO1998034637A1 Use of a polypeptide for obtaining a composition for detecting, preventing or treating a degenerative and/or autoimmune disease
1 ... 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 ... 1172